Sage Therapeutics (SAGE) 324 Data is Positive but More Detail on Side Effects is Needed - Mizuho Securities
Go back to Sage Therapeutics (SAGE) 324 Data is Positive but More Detail on Side Effects is Needed - Mizuho Securities| BIOGEN IDEC Inc. (NASDAQ: BIIB) | Delayed: 209.83 -0.82 (0.39%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $210.65 | 52 Week High | $333.65 | |||
| Open | $210.01 | 52 Week Low | $223.02 | |||
| Day High | $210.79 | P/E | 26.87 | |||
| Day Low | $208.22 | EPS | $7.81 | |||
| Volume | 554,817 | |||||
| Sagebrush Gold Ltd. (NASDAQ: SAGE) | Delayed: 8.68 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $8.68 | 52 Week High | $62.64 | |||
| Open | $8.68 | 52 Week Low | $26.28 | |||
| Day High | $8.68 | P/E | N/A | |||
| Day Low | $8.68 | EPS | $-0.94 | |||
| Volume | 276,126 | |||||
